Exelixis Inc (EXEL)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
EXEL price, last 12 months
Key stats
- Previous close
- $68.29
- Open
- $68.18
- Day range
- $65.36 – $68.51
- 52-week range
- $39.71 – $73.69
- Volume
- 2.7M
- Avg volume (20 days)
- 3M
- Market cap
- $16.8B
Performance
Technicals and fundamentals
About Exelixis Inc
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $16.8B